<?xml version="1.0" encoding="UTF-8"?>

<CodeSystem xmlns="http://hl7.org/fhir">
  <id value="nkrs-variables"/>
  <text>
    <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p>This code system http://fhir.ch/ig/ch-crl/CodeSystem/nkrs-variables defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style="white-space:nowrap">3.6.2<a name="nkrs-variables-3.466.462"> </a></td><td>Associated in situ tumour</td></tr><tr><td style="white-space:nowrap">3.9.1<a name="nkrs-variables-3.469.461"> </a></td><td>ICCC-3 main group</td></tr><tr><td style="white-space:nowrap">3.9.2<a name="nkrs-variables-3.469.462"> </a></td><td>ICCC-3 code</td></tr><tr><td style="white-space:nowrap">3.9.3<a name="nkrs-variables-3.469.463"> </a></td><td>ICCC-3 extended code</td></tr><tr><td style="white-space:nowrap">4.19<a name="nkrs-variables-4.4619"> </a></td><td>COG staging</td></tr><tr><td style="white-space:nowrap">4.20<a name="nkrs-variables-4.4620"> </a></td><td>COG ALL staging</td></tr><tr><td style="white-space:nowrap">4.21<a name="nkrs-variables-4.4621"> </a></td><td>FIGO staging</td></tr><tr><td style="white-space:nowrap">4.22<a name="nkrs-variables-4.4622"> </a></td><td>INRGSS staging</td></tr><tr><td style="white-space:nowrap">4.23<a name="nkrs-variables-4.4623"> </a></td><td>IRSS staging</td></tr><tr><td style="white-space:nowrap">4.24<a name="nkrs-variables-4.4624"> </a></td><td>Lugano staging</td></tr><tr><td style="white-space:nowrap">4.25<a name="nkrs-variables-4.4625"> </a></td><td>PRETEXT staging</td></tr><tr><td style="white-space:nowrap">4.28<a name="nkrs-variables-4.4628"> </a></td><td>Rhabdomyosarcoma site staging</td></tr><tr><td style="white-space:nowrap">4.30<a name="nkrs-variables-4.4630"> </a></td><td>DSSplus</td></tr><tr><td style="white-space:nowrap">4.31<a name="nkrs-variables-4.4631"> </a></td><td>SIOP staging</td></tr><tr><td style="white-space:nowrap">4.32<a name="nkrs-variables-4.4632"> </a></td><td>St. Jude / Murphy staging</td></tr><tr><td style="white-space:nowrap">4.33.2<a name="nkrs-variables-4.4633.462"> </a></td><td>Toronto Tier II (manual) staging</td></tr><tr><td style="white-space:nowrap">4.34<a name="nkrs-variables-4.4634"> </a></td><td>Creasman grading system</td></tr><tr><td style="white-space:nowrap">4.35<a name="nkrs-variables-4.4635"> </a></td><td>Elston/Ellis grading system</td></tr><tr><td style="white-space:nowrap">4.36<a name="nkrs-variables-4.4636"> </a></td><td>SalzerKuntschik grading system</td></tr><tr><td style="white-space:nowrap">4.37<a name="nkrs-variables-4.4637"> </a></td><td>Shimada grading system</td></tr><tr><td style="white-space:nowrap">4.38<a name="nkrs-variables-4.4638"> </a></td><td>WHO(CNS) grading system</td></tr><tr><td style="white-space:nowrap">4.39<a name="nkrs-variables-4.4639"> </a></td><td>Clinical tumour size</td></tr><tr><td style="white-space:nowrap">4.40<a name="nkrs-variables-4.4640"> </a></td><td>Pathological tumour size</td></tr><tr><td style="white-space:nowrap">6.1<a name="nkrs-variables-6.461"> </a></td><td>Residual invasive tumour</td></tr><tr><td style="white-space:nowrap">6.2<a name="nkrs-variables-6.462"> </a></td><td>Residual in-situ tumour</td></tr><tr><td style="white-space:nowrap">6.3<a name="nkrs-variables-6.463"> </a></td><td>Resection margin invasive tumour</td></tr><tr><td style="white-space:nowrap">6.4<a name="nkrs-variables-6.464"> </a></td><td>Resection margin in-situ tumour</td></tr><tr><td style="white-space:nowrap">8.4<a name="nkrs-variables-8.464"> </a></td><td>Morphology term before change of main diagnosis</td></tr><tr><td style="white-space:nowrap">8.5<a name="nkrs-variables-8.465"> </a></td><td>Morphology term after Transformation</td></tr><tr><td style="white-space:nowrap">8.6<a name="nkrs-variables-8.466"> </a></td><td>Topography(s) of post-diagnosis metastases</td></tr><tr><td style="white-space:nowrap">10.3<a name="nkrs-variables-10.463"> </a></td><td>HIV/AIDS</td></tr><tr><td style="white-space:nowrap">10.9<a name="nkrs-variables-10.469"> </a></td><td>Cerebrovascular Accident or Transient Ischemic Attack</td></tr><tr><td style="white-space:nowrap">10.11<a name="nkrs-variables-10.4611"> </a></td><td>Hemiplegia / Paraplegia</td></tr><tr><td style="white-space:nowrap">10.12<a name="nkrs-variables-10.4612"> </a></td><td>Connective Tissue Disease - Rheumatic disease</td></tr></table></div>
  </text>
  <url value="http://fhir.ch/ig/ch-crl/CodeSystem/nkrs-variables"/>
  <version value="0.9.0"/>
  <name value="NkrsVariables"/>
  <title value="NKRS Variables"/>
  <status value="active"/>
  <date value="2022-02-04T14:14:21+01:00"/>
  <publisher value="Bundesamt für Gesundheit BAG"/>
  <contact>
    <name value="Bundesamt für Gesundheit BAG"/>
    <telecom>
      <system value="url"/>
      <value value="https://www.bag.admin.ch/"/>
    </telecom>
  </contact>
  <description value="NKRS codes for data elements for which there is no international code (e.g. LOINC or SNOMED CT) &#xD;&#xA;that accurately describes the meaning of the NKRS variable. This code system is based on &#xD;&#xA;\&#39;NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)\&#39;&#xD;&#xA;([EN](https://www.nacr.ch/assets/files/uploads/a-datadictionary-basicvariables-v1.1.pdf), &#xD;&#xA;[DE](https://www.nkrs.ch/assets/files/uploads/a-datenstruktur-variablen-der-basisdaten-v1.1.pdf), &#xD;&#xA;[FR](https://www.onec.ch/assets/files/uploads/a-dict-des-donnees-variables-de-base-v1.1.pdf), &#xD;&#xA;[IT](https://www.snrt.ch/assets/files/uploads/a-dati-oncologici-variabili-di-base-v1.1.pdf)) &#xD;&#xA;and &#xD;&#xA;\&#39;NATIONAL CANCER DATA DICTIONARY, V 1.1, Part B1, SUPPLEMENTARY VARIABLES for Adults (15.10.2019)\&#39;&#xD;&#xA;([EN](https://www.nacr.ch/assets/files/uploads/b1-datadictionary-supplementaryvariables-adults-v1.1.pdf), &#xD;&#xA;[DE](https://www.nkrs.ch/assets/files/uploads/variablen-zusatzdaten-kinderjugendliche-v1.1.pdf), &#xD;&#xA;[FR](https://www.onec.ch/assets/files/uploads/b1-dict-des-donnees-variables-suppl-adultes-v1.1.pdf), &#xD;&#xA;[IT](https://www.snrt.ch/assets/files/uploads/b1-variabili-supplementari-adulti-v1.1.pdf))."/>
  <jurisdiction>
    <coding>
      <system value="urn:iso:std:iso:3166"/>
      <code value="CH"/>
    </coding>
  </jurisdiction>
  <copyright value="CC-BY-SA-4.0"/>
  <caseSensitive value="true"/>
  <content value="complete"/>
  <count value="34"/>
  <concept>
    <code value="3.6.2"/>
    <display value="Associated in situ tumour"/>
  </concept>
  <concept>
    <code value="3.9.1"/>
    <display value="ICCC-3 main group"/>
  </concept>
  <concept>
    <code value="3.9.2"/>
    <display value="ICCC-3 code"/>
  </concept>
  <concept>
    <code value="3.9.3"/>
    <display value="ICCC-3 extended code"/>
  </concept>
  <concept>
    <code value="4.19"/>
    <display value="COG staging"/>
  </concept>
  <concept>
    <code value="4.20"/>
    <display value="COG ALL staging"/>
  </concept>
  <concept>
    <code value="4.21"/>
    <display value="FIGO staging"/>
  </concept>
  <concept>
    <code value="4.22"/>
    <display value="INRGSS staging"/>
  </concept>
  <concept>
    <code value="4.23"/>
    <display value="IRSS staging"/>
  </concept>
  <concept>
    <code value="4.24"/>
    <display value="Lugano staging"/>
  </concept>
  <concept>
    <code value="4.25"/>
    <display value="PRETEXT staging"/>
  </concept>
  <concept>
    <code value="4.28"/>
    <display value="Rhabdomyosarcoma site staging"/>
  </concept>
  <concept>
    <code value="4.30"/>
    <display value="DSSplus"/>
  </concept>
  <concept>
    <code value="4.31"/>
    <display value="SIOP staging"/>
  </concept>
  <concept>
    <code value="4.32"/>
    <display value="St. Jude / Murphy staging"/>
  </concept>
  <concept>
    <code value="4.33.2"/>
    <display value="Toronto Tier II (manual) staging"/>
  </concept>
  <concept>
    <code value="4.34"/>
    <display value="Creasman grading system"/>
  </concept>
  <concept>
    <code value="4.35"/>
    <display value="Elston/Ellis grading system"/>
  </concept>
  <concept>
    <code value="4.36"/>
    <display value="SalzerKuntschik grading system"/>
  </concept>
  <concept>
    <code value="4.37"/>
    <display value="Shimada grading system"/>
  </concept>
  <concept>
    <code value="4.38"/>
    <display value="WHO(CNS) grading system"/>
  </concept>
  <concept>
    <code value="4.39"/>
    <display value="Clinical tumour size"/>
  </concept>
  <concept>
    <code value="4.40"/>
    <display value="Pathological tumour size"/>
  </concept>
  <concept>
    <code value="6.1"/>
    <display value="Residual invasive tumour"/>
  </concept>
  <concept>
    <code value="6.2"/>
    <display value="Residual in-situ tumour"/>
  </concept>
  <concept>
    <code value="6.3"/>
    <display value="Resection margin invasive tumour"/>
  </concept>
  <concept>
    <code value="6.4"/>
    <display value="Resection margin in-situ tumour"/>
  </concept>
  <concept>
    <code value="8.4"/>
    <display value="Morphology term before change of main diagnosis"/>
  </concept>
  <concept>
    <code value="8.5"/>
    <display value="Morphology term after Transformation"/>
  </concept>
  <concept>
    <code value="8.6"/>
    <display value="Topography(s) of post-diagnosis metastases"/>
  </concept>
  <concept>
    <code value="10.3"/>
    <display value="HIV/AIDS"/>
  </concept>
  <concept>
    <code value="10.9"/>
    <display value="Cerebrovascular Accident or Transient Ischemic Attack"/>
  </concept>
  <concept>
    <code value="10.11"/>
    <display value="Hemiplegia / Paraplegia"/>
  </concept>
  <concept>
    <code value="10.12"/>
    <display value="Connective Tissue Disease - Rheumatic disease"/>
  </concept>
</CodeSystem>